Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0I0MU
|
|||
Former ID |
DNC006564
|
|||
Drug Name |
Cbz-Ile-Leu-Ala-LeuVSMe
|
|||
Synonyms |
CHEMBL207403; Cbz-Ile-Leu-Ala-LeuVSMe
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C31H50N4O7S
|
|||
Canonical SMILES |
CCC(C)C(C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC(C)C)C=CS(=O)(=O)C)NC(=O)OCC1=CC=CC=C1
|
|||
InChI |
1S/C31H50N4O7S/c1-9-22(6)27(35-31(39)42-19-24-13-11-10-12-14-24)30(38)34-26(18-21(4)5)29(37)32-23(7)28(36)33-25(17-20(2)3)15-16-43(8,40)41/h10-16,20-23,25-27H,9,17-19H2,1-8H3,(H,32,37)(H,33,36)(H,34,38)(H,35,39)/b16-15+/t22-,23-,25+,26-,27-/m0/s1
|
|||
InChIKey |
PXJWGKDQRNBYKI-HUHPYHTRSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cathepsin B (CTSB) | Target Info | Inhibitor | [1] |
Cathepsin S (CTSS) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Lysosome | |||
Antigen processing and presentation | ||||
Phagosome | ||||
Tuberculosis | ||||
NetPath Pathway | TCR Signaling Pathway | |||
IL2 Signaling Pathway | ||||
Leptin Signaling Pathway | ||||
Reactome | Collagen degradation | |||
Trafficking and processing of endosomal TLR | ||||
Assembly of collagen fibrils and other multimeric structures | ||||
MHC class II antigen presentation | ||||
Endosomal/Vacuolar pathway | ||||
Degradation of the extracellular matrix | ||||
WikiPathways | Class I MHC mediated antigen processing & presentation | |||
Trafficking and processing of endosomal TLR |
References | Top | |||
---|---|---|---|---|
REF 1 | Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and c... J Med Chem. 2006 May 18;49(10):2953-68. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.